QQ客服 官方微博 反馈留言

	A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia
	Qin, Yan; Han, Xiaohong; Wang, Lin; Du, Ping; Yao, Jiarui; Wu, Di; Song, Yuanyuan; Zhang, Shuxiang; Tang, Le; Shi, Yuankai
	2017
卷号	29期号:5页码:402-410
关键词	Phase I study chemotherapy dose-finding neutropenia PEG rhG-CSF
ISSN号	1000-9604
DOI	10.21147/j.issn.1000-9604.2017.05.04
URL标识	查看原文
收录类别	SCIE ; PUBMED ; CSCD
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6362025
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Qin, Yan,Han, Xiaohong,Wang, Lin,et al. A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia[J],2017,29(5):402-410.
APA	Qin, Yan.,Han, Xiaohong.,Wang, Lin.,Du, Ping.,Yao, Jiarui.,...&Shi, Yuankai.(2017).A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.,29(5),402-410.
MLA	Qin, Yan,et al."A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia".29.5(2017):402-410.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。